Literature DB >> 25710917

MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage.

Zhao Yang1, Lina Zhong1, Ronghua Xian2, Bangqing Yuan3.   

Abstract

NLRP3 inflammasome, the multimeric protein complexes involved in the processing of IL-1β through Caspase-1 cleavage, facilitates the inflammatory response. The control and activation of NLRP3 after intracerebral hemorrhage have not been fully studied. In the current study, we explore the specific microRNA which could regulate the NLRP3 inflammasome and inflammation after intracerebral hemorrhage. We detected the inverse relationship between the expression of miR-223 and NLRP3. We found that NLRP3 mRNA contains conserved miR-223 binding sites in its 3' UTR, and miR-223 could directly regulate NLRP3 expression through these 3' UTR sites. Our results indicate that miR-223 could downregulate NLRP3 to inhibit inflammation through caspase-1 and IL-1β, reduce brain edema and improve neurological functions. Together, miR-223 may be a vital regulator of NLRP3 inflammasome activation. The results suggest that miR-223 represents a novel target reducing the inflammatory response, and offers a new therapeutical strategy following ICH.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Brain injury; Inflammation; Intracerebral hemorrhage; MicroRNA-223; NLRP3

Mesh:

Substances:

Year:  2015        PMID: 25710917     DOI: 10.1016/j.molimm.2014.12.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  51 in total

1.  A Polymorphism Within the 3'UTR of NLRP3 is Associated with Susceptibility for Ischemic Stroke in Chinese Population.

Authors:  Zhansheng Zhu; Jing Yan; Chunsong Geng; Dagang Wang; Chaoyang Li; Shuai Feng; Huiping Wang
Journal:  Cell Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.046

2.  Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation.

Authors:  Yijun Cheng; Yongxu Wei; Wenlei Yang; Yaying Song; Hanbing Shang; Yu Cai; Zhebao Wu; Weiguo Zhao
Journal:  Metab Brain Dis       Date:  2017-04-11       Impact factor: 3.584

Review 3.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.

Authors:  Jin Kyung Kim; Hyo Sun Jin; Hyun-Woo Suh; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

4.  HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.

Authors:  Ernest T Chivero; Ming-Lei Guo; Palsamy Periyasamy; Ke Liao; Shannon E Callen; Shilpa Buch
Journal:  J Neurosci       Date:  2017-03-07       Impact factor: 6.167

Review 5.  The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke.

Authors:  Shao-Jun Yang; Gao-Feng Shao; Jiang-Li Chen; Jie Gong
Journal:  Cell Mol Neurobiol       Date:  2017-07-27       Impact factor: 5.046

6.  Sinomenine Attenuates Cartilage Degeneration by Regulating miR-223-3p/NLRP3 Inflammasome Signaling.

Authors:  Hai-Chao Dong; Pei-Nan Li; Chang-Jian Chen; Xin Xu; Hong Zhang; Gang Liu; Lian-Jie Zheng; Peng Li
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

Review 7.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

8.  Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury.

Authors:  Xin Wei; Chen-Chen Hu; Ya-Li Zhang; Shang-Long Yao; Wei-Ke Mao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 9.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

10.  Role of Exosomes Derived from miR-133b Modified MSCs in an Experimental Rat Model of Intracerebral Hemorrhage.

Authors:  Haitao Shen; Xiyang Yao; Haiying Li; Xiang Li; Tiejun Zhang; Qing Sun; Chengyuan Ji; Gang Chen
Journal:  J Mol Neurosci       Date:  2018-02-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.